4//SEC Filing
Alspaugh Jonathan 4
Accession 0001209191-21-046007
CIK 0001636282other
Filed
Jul 7, 8:00 PM ET
Accepted
Jul 8, 5:12 PM ET
Size
5.6 KB
Accession
0001209191-21-046007
Insider Transaction Report
Form 4
Alspaugh Jonathan
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2021-07-06+160,000→ 160,000 totalExercise: $7.03Exp: 2031-07-05→ Common Stock (160,000 underlying)
Footnotes (1)
- [F1]The options will vest as to 1/4th of the total shares on July 6, 2022, and then 1/48th of the shares will vest monthly thereafter, such that the option is fully vested on July 6, 2025, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Documents
Issuer
Aeglea BioTherapeutics, Inc.
CIK 0001636282
Entity typeother
Related Parties
1- filerCIK 0001868112
Filing Metadata
- Form type
- 4
- Filed
- Jul 7, 8:00 PM ET
- Accepted
- Jul 8, 5:12 PM ET
- Size
- 5.6 KB